{"id":1003000,"date":"2026-04-15T10:50:12","date_gmt":"2026-04-15T05:20:12","guid":{"rendered":"https:\/\/telecomlive.in\/web\/?p=1003000"},"modified":"2026-04-15T11:14:48","modified_gmt":"2026-04-15T05:44:48","slug":"novo-nordisk-signs-deal-with-openai-to-develop-new-drugs","status":"publish","type":"post","link":"https:\/\/telecomlive.in\/web\/2026\/04\/15\/novo-nordisk-signs-deal-with-openai-to-develop-new-drugs\/","title":{"rendered":"Novo Nordisk signs deal with OpenAI to develop new drugs"},"content":{"rendered":"<p>Danish pharmaceuticals group Novo Nordisk, maker of the popular Ozempic and Wegovy anti-obesity drugs, announced Tuesday a &#8220;strategic partnership&#8221; with OpenAI to accelerate the development of new medications. <\/p>\n<p>Novo Nordisk said the partnership would place it &#8220;at the forefront of AI transformation in healthcare and help the company bring new and better treatment options to patients faster&#8221;.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Danish pharmaceuticals group Novo Nordisk, maker of the popular Ozempic and Wegovy anti-obesity drugs, announced Tuesday a &#8220;strategic partnership&#8221; with OpenAI to accelerate the development of new medications. Novo Nordisk said the partnership would place it &#8220;at the forefront of AI transformation in healthcare and help the company bring new and better treatment options to patients faster&#8221;.<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[59,4,10],"tags":[],"class_list":["post-1003000","post","type-post","status-publish","format-standard","hentry","category-it-2-the-economic-times","category-newspapers","category-the-economic-times"],"acf":[],"_links":{"self":[{"href":"https:\/\/telecomlive.in\/web\/wp-json\/wp\/v2\/posts\/1003000","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/telecomlive.in\/web\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/telecomlive.in\/web\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/telecomlive.in\/web\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/telecomlive.in\/web\/wp-json\/wp\/v2\/comments?post=1003000"}],"version-history":[{"count":0,"href":"https:\/\/telecomlive.in\/web\/wp-json\/wp\/v2\/posts\/1003000\/revisions"}],"wp:attachment":[{"href":"https:\/\/telecomlive.in\/web\/wp-json\/wp\/v2\/media?parent=1003000"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/telecomlive.in\/web\/wp-json\/wp\/v2\/categories?post=1003000"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/telecomlive.in\/web\/wp-json\/wp\/v2\/tags?post=1003000"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}